Discover the latest news from the Pulmonary Hypertension, including advocacy updates, research articles and event coverage.
People with pulmonary hypertension face higher risks from flu and COVID-19. Stay protected by getting recommended vaccines this fall.
News
Sickle Cell and Pulmonary Fibrosis Awareness Month highlights how associated conditions can increase the risk of pulmonary hypertension.
News
Hear from leading PH experts at PHA’s PH Wellness Expo in San Francisco, with exhibits, advocacy sessions and family fun.
Events | News
The new issue of Pathlight is here. Explore inspiring stories in PHA’s quarterly magazine, available online and by mail.
News
People with pulmonary hypertension face greater risks from air pollution. Learn symptoms, risks and prevention tips.
News
New Medicaid work requirements take effect in 2027 in most states. See who may need to comply to keep coverage.
Insurance & treatment access | News
The label references trial data that shows the drug as safe and effective for moderate to high-risk PAH.
Pulmovant is enrolling participants in its Phase 3 mosliciguat study after positive Phase 2 results.
The FDA will review United Therapeutic’s new drug application for Ralinepag, a once-daily pill to treat PAH.
